ReviewClinics in chest medicine2008
Pulmonary hypertension caused by sarcoidosis.
Review in Clinics in chest medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 68 citations in OpenAlex.
- Sarcoidosis Associated Pulmonary Hypertension.Biomedicines · 2024Review
- Pulmonary fibrosis in sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023Article
- The Role of Echocardiography in the Contemporary Diagnosis and Prognosis of Cardiac Sarcoidosis: A Comprehensive Review.Life (Basel, Switzerland) · 2023Review
- Management of Sarcoidosis-associated Pulmonary Hypertension.Clinical medicine & research · 2020Article
- Author Response: Pulmonary Vasodilators in Sarcoidosis-associated Pulmonary Hypertension.Clinical medicine & research · 2020Article
- Sarcoidosis: Pitfalls and Challenging Mimickers.Frontiers in medicine · 2020Review
- Tattoo Koebnerization and Severe Pulmonary Hypertension.Clinical medicine & research · 2019Article
- The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.Antioxidants & redox signaling · 2019Review
- The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2017Article
- Rare causes of pulmonary hypertension: spectrum of radiological findings and review of the literature.La Radiologia medica · 2014Review
- A concise review of pulmonary sarcoidosis.American journal of respiratory and critical care medicine · 2011Review
- Mimickers of chronic thromboembolic pulmonary hypertension on imaging tests: a review.Pulmonary circulationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Pulmonary hypertension is an uncommon complication of sarcoidosis, but in severe pulmonary disease it occurs frequently. It is an important cause of cryptogenic dyspnea in sarcoidosis patients and can occur despite the absence of pulmonary fibrosis. The true prevalence is unknown. With the advent of specific therapies for pulmonary hypertension, there has been a resurgence of interest in the pathophysiology, diagnosis, and treatment of sarcoidosis-associated pulmonary hypertension. This article reviews the status of the current epidemiologic, pathophysiologic, and therapeutic knowledge regarding this entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.